CENCORA INC

Explore Cencora’s 26 Nov 2026 stock update: $331 per share, 2.21% drop, market cap $63.2 billion, and context from pharma breakthroughs and market trends.

Discover why Cencora’s stock, trading at $334.88, sits above its 200‑day SMA and may be a solid long‑term buy for investors in the stable pharma sector.

Explore why Cencora’s stock slipped amid market uncertainty, its technical position, and what regulatory and competitive forces could shape future value.

Explore Cencora’s latest market trends and earnings outlook—anticipate a positive EPS swing, revenue growth, and strong OTC/home‑care expansion.